written by reader Non-opioid painkiller using Tolperisone; Neurana Pharmaceuticals

By jj11202, January 4, 2021

Neurana appears to be having success in the development of a non-opioid pain reliever using Tolperisone for acute muscle spasms. They are now in phase 3 trials. Neurana is a privately held company. Does anyone know who their industry partner might be? Any ideas on how to invest in their future upside before they get purchased or do an IPO?

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.